Cargando…

A Novel Magnetic Resonance Imaging-Based Radiomics and Clinical Predictive Model for the Regrowth of Postoperative Residual Tumor in Non-Functioning Pituitary Neuroendocrine Tumor

Background and Objectives: To develop a novel magnetic resonance imaging (MRI)-based radiomics–clinical risk stratification model to predict the regrowth of postoperative residual tumors in patients with non-functioning pituitary neuroendocrine tumors (NF-PitNETs). Materials and Methods: We retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Chaodong, Liu, Xiaoyan, Jin, Jinghao, Han, Cheng, Wu, Lihao, Wu, Zerui, Su, Zhipeng, Chen, Xiaofang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10535289/ https://www.ncbi.nlm.nih.gov/pubmed/37763643 http://dx.doi.org/10.3390/medicina59091525

Ejemplares similares

Residual Tumor Confers a 10-Fold Increased Risk of Regrowth in Clinically Nonfunctioning Pituitary Tumors
por: Maletkovic, Jelena, et al.
Publicado: (2019)

Prediction using T2‐weighted magnetic resonance imaging‐based radiomics of residual uterine myoma regrowth after high‐intensity focused ultrasound ablation
por: Zhou, Y., et al.
Publicado: (2022)

Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas
por: Wu, Zerui, et al.
Publicado: (2021)

Pituitary Neuroendocrine Tumor: Is It Benign or Malignant?
por: Lee, Chae Heuck
Publicado: (2023)

Oxidative stress in pituitary neuroendocrine tumors: Affecting the tumor microenvironment and becoming a new target for pituitary neuroendocrine tumor therapy
por: Zhou, Yuhang, et al.
Publicado: (2023)

Pituitary Apoplexy in Patients with Pituitary Neuroendocrine Tumors (PitNET)
por: Gheorghe, Ana-Maria, et al.
Publicado: (2023)

Characteristic of Tumor Regrowth After Gamma Knife Radiosurgery and Outcomes of Repeat Gamma Knife Radiosurgery in Nonfunctioning Pituitary Adenomas
por: Li, Yanli, et al.
Publicado: (2021)

Biomarkers for Liquid Biopsies of Pituitary Neuroendocrine Tumors
por: Gossing, Wilhelm, et al.
Publicado: (2020)

Transcriptomic Profiles of Normal Pituitary Cells and Pituitary Neuroendocrine Tumor Cells
por: Oh, Jun Y., et al.
Publicado: (2022)

PD-L1 Expression in Pituitary Neuroendocrine Tumors/Pituitary Adenomas
por: Cossu, Giulia, et al.
Publicado: (2023)

Pseudocapsule and pseudocapsule-based extracapsular resection in pituitary neuroendocrine tumors
por: Wang, Xiao Bin, et al.
Publicado: (2022)

Identification of the enhancer RNAs related to tumorgenesis of pituitary neuroendocrine tumors
por: Wang, Liangbo, et al.
Publicado: (2023)

Predicting the regrowth of clinically non-functioning pituitary adenoma with a statistical model
por: Cheng, Sen, et al.
Publicado: (2019)

A potential impact of SARS-CoV-2 on pituitary glands and pituitary neuroendocrine tumors
por: Gu, Wei Ting, et al.
Publicado: (2021)

Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective
por: Liu, Xiaohai, et al.
Publicado: (2021)

Histopathological classification of non-functioning pituitary neuroendocrine tumors
por: Manojlovic-Gacic, Emilija, et al.
Publicado: (2017)

Chromosomal instability in the prediction of pituitary neuroendocrine tumors prognosis
por: Lasolle, Hélène, et al.
Publicado: (2020)

An Update on Pituitary Neuroendocrine Tumors Leading to Acromegaly and Gigantism
por: Asa, Sylvia L., et al.
Publicado: (2021)

Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors
por: Fujiwara, Ren, et al.
Publicado: (2022)

Transcriptomic Classification of Pituitary Neuroendocrine Tumors Causing Acromegaly
por: Rymuza, Julia, et al.
Publicado: (2022)

Proteogenomic landscape and clinical characterization of GH-producing pituitary adenomas/somatotroph pituitary neuroendocrine tumors
por: Yamato, Azusa, et al.
Publicado: (2022)

THU083 Disulfiram Mediated Anti-tumor Effect In Pituitary Neuroendocrine Tumors By Inducing Cuproptosis
por: Huang, Ning, et al.
Publicado: (2023)

Time‐Dependent Bias of Tumor Growth Rate and Time to Tumor Regrowth
por: Mistry, HB
Publicado: (2016)

Radiotherapy and risks of tumor regrowth or inducing second cancer
por: Moawad, Emad Y.
Publicado: (2011)

Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Primary pituitary neuroendocrine tumor: Case report and literature review
por: Nasi, D., et al.
Publicado: (2017)

How to Classify Pituitary Neuroendocrine Tumors (PitNET)s in 2020
por: Trouillas, Jacqueline, et al.
Publicado: (2020)

Single-cell transcriptome and genome analyses of pituitary neuroendocrine tumors
por: Cui, Yueli, et al.
Publicado: (2021)

Annotation of pituitary neuroendocrine tumors with genome-wide expression analysis
por: Tebani, Abdellah, et al.
Publicado: (2021)

Persistent Hypokalemia Induced by an Intracavernous Ectopic Pituitary Neuroendocrine Tumor
por: Ito, Saya, et al.
Publicado: (2022)

Correction to: Imaging of pituitary tumors: an update with the 5th WHO Classifications—part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma
por: Tsukamoto, Taro, et al.
Publicado: (2023)

Detection of tumor-specific DNA methylation markers in the blood of patients with pituitary neuroendocrine tumors
por: Herrgott, Grayson A, et al.
Publicado: (2022)

Role of Tumor Microenvironment in Pituitary Neuroendocrine Tumors: New Approaches in Classification, Diagnosis and Therapy
por: Tapoi, Dana Antonia, et al.
Publicado: (2023)

Identification of biomarkers associated with the invasion of nonfunctional pituitary neuroendocrine tumors based on the immune microenvironment
por: Wu, Jiangping, et al.
Publicado: (2023)

Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors
por: Zhang, Fan, et al.
Publicado: (2022)

Pre- and postoperative magnetic resonance imaging appearance of the normal residual pituitary gland following macroadenoma resection: Clinical implications
por: Maio, Salvatore Di, et al.
Publicado: (2012)

Therapeutic Injury and Tumor Regrowth: Tumor Resection and Radiation Establish the Recurrent Glioblastoma Microenvironment
por: Silver, Daniel J., et al.
Publicado: (2018)

Splicing Machinery is Dysregulated in Pituitary Neuroendocrine Tumors and is Associated with Aggressiveness Features
por: Vázquez-Borrego, Mari C., et al.
Publicado: (2019)

Progress in the Pathogenesis, Diagnosis, and Treatment of TSH-Secreting Pituitary Neuroendocrine Tumor
por: Luo, Peiqiong, et al.
Publicado: (2020)

Single Cell Metabolic Landscape of Pituitary Neuroendocrine Tumor Subgroups and Lineages
por: Batchu, Sai, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3h7kstgmasc65c9t8n98vvdfr9